The legacy of Viagra and its impact on the pharmaceutical landscape presents a intriguing question for shareholders . Initially a massive drug, generics have significantly chipped away at its market share , creating challenges for companies involved to the original patent holder and subsequent formulas. While some businesses might gain from focused